Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

ANI Pharma Inc (ANIP)

ANI Pharma Inc (ANIP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

ANI Pharma Inc 210 Main Street West Baudette MN 56623 USA

www.anipharmaceuticals.com P: 218-634-3500

Description:

ANI Pharmaceuticals, Inc. is a specialty pharmaceutical company. It engaged in developing, manufacturing and marketing branded and generic prescription pharmaceuticals. The company offers liquid, powder, oral solid dose, cough/cold products, antacids, laxatives, stomach remedies as well as hydrocortisone retention enema, esterified estrogen and methyltestosterone, fluvoxamine maleate tablets, hydrocortisone rectal suspension, metoclopramide oral solution, opium tincture and metoclopramide tablets. In addition, it offers contract manufacturing services for other pharmaceutical companies. The company serves through wholesalers, smaller regional distributors and chains and pharmacy and retail outlets primarily in the United States. ANI Pharmaceuticals, Inc., formerly known as BioSante Pharmaceuticals, Inc., is headquartered in Baudette, MN.

Key Statistics

Overview:

Market Capitalization, $K 1,397,538
Enterprise Value, $K 1,486,938
Shares Outstanding, K 21,079
Annual Sales, $ 486,820 K
Annual Net Income, $ 18,780 K
Last Quarter Sales, $ 131,650 K
Last Quarter Net Income, $ 1,160 K
EBIT, $ 106,760 K
EBITDA, $ 166,550 K
60-Month Beta 0.79
% of Insider Shareholders 12.70%
% of Institutional Shareholders 76.05%
Float, K 18,402
% Float 87.30%
Short Volume Ratio 0.55

Growth:

1-Year Return 72.57%
3-Year Return 101.21%
5-Year Return -6.32%
5-Year Revenue Growth 141.50%
5-Year Earnings Growth -16.49%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 1.00 on 02/29/24
Latest Earnings Date 05/13/24
Earnings Per Share ttm 3.86
EPS Growth vs. Prev Qtr -25.71%
EPS Growth vs. Prev Year 32.20%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-6 on 07/18/13

ANIP Ratios

Ratio
Price/Earnings ttm 17.33
Price/Earnings forward 18.87
Price/Earnings to Growth N/A
Return-on-Equity % 18.06%
Return-on-Assets % 8.38%
Profit Margin % 3.86%
Debt/Equity 0.62
Price/Sales 2.90
Price/Cash Flow 10.42
Price/Book 3.16
Book Value/Share 22.34
Interest Coverage -1.74
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar